<DOC>
	<DOCNO>NCT00234312</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety flexible dos escitalopram ( Lexapro ) compare sertraline ( Zoloft ) treatment Dysthymic Disorder .</brief_summary>
	<brief_title>Medications Treatment Dysthymic Disorder Double Depression</brief_title>
	<detailed_description>Dysthymic Disorder common , chronic type depression often see mild condition under-treated . Because chronic course , often complicate episode major depression may require long-term treatment . This twelve week study daily dos escitalopram ( 10-20 mg ) sertraline ( 50-200 mg ) give outpatient meet criterion Dysthymic Disorder Double Depression . Medications assign 1:1 clinician blind treatment . Efficacy base score Hamilton Depression Rating Scale , patient subjective reporting , clinician observation . The study total 8 visit 12 week , one-week medication taper period end . Subjects physical exam , lab , vital sign monitor first visit vital sign monitor every subsequent visit . Women childbearing potential must negative urine pregnancy test screening . All subject remain low medication dose first four week study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Dysthymic Disorder</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Primary diagnosis Dysthymic Disorder Major Depressive Disorder Antecedent Dysthymia Women childbearing potential must negative pregnancy test screen agree practice acceptable method birth control Score least 12 24item Hamilton Depression Scale study entry Initial screen lab grossly within normal limit Signed write informed consent Other AxisI diagnose delirium , dementia , substance dependence ( active last year ) substance abuse include alcohol within past six month Actively suicidal CNS neoplasm , demyelinization disease , degenerative neurological disorder , active CNS infection , progressive CNS disorder may confound interpretation study result History seizure disorder , EEG show paroxysmal activity head CT show gross structural abnormality Acute systemic medical disorder Use psychotropic medication within 2 week prior screen 4 week prior screen case fluoxetine Current use herbal medication St. John 's wort , Uncontrolled renal , hepatic , endocrine , cardiovascular , pulmonary , immunological , hematological gastrointestinal disease Any abnormal medical screening test judge investigator clinically significant Received experimental medication within 30 day prior study entry Patients presently soon start psychotherapy Prior treatment nonresponse adequate trial citalopram , escitalopram , sertraline History allergy citalopram , escitalopram sertraline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Depressive Disorders</keyword>
</DOC>